Combining Next-Generation Sequencing and Immune Assays: A Novel Method for Identification of Antigen-Specific T Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Klinger, Mark ^a   Kong, Katherine ^a   Moorhead, Martin ^a   Weng, Li ^a   Zheng, Jianbiao ^a   Faham, Malek ^a  

^a Sequenta Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; T LYMPHOCYTE RECEPTOR;

ANTIGEN SPECIFICITY; ARTICLE; CELL SELECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; FLOW CYTOMETRY; GENE SEQUENCE; IMMUNOASSAY; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; NONHUMAN; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

AMINO ACID SEQUENCE; ANTIGENS; ANTIGENS, CD137; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; COMPLEMENTARITY DETERMINING REGIONS; CYTOMEGALOVIRUS; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOASSAY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; PHOSPHOPROTEINS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; VIRAL MATRIX PROTEINS;

EID: 84884359333     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074231     Document Type: Article

References (34)

1. Keilholz U, Martus P, Scheibenbogen C, (2006) Immune monitoring of T-cell responses in cancer vaccine development. Clin Cancer Res 12: 2346s-2352s.
2. Li Pira G, Kern F, Gratama J, Roederer M, Manca F, (2007) Measurement of antigen specific immune responses: 2006 update. Cytometry B Clin Cytom 72: 77-85.
3. Gratama JW, Kern F, Manca F, Roederer M, (2008) Measuring antigen-specific immune responses, 2008 update. Cytometry A 73: 971-974.
4. Campbell JD, Buchmann P, Kesting S, Cunningham CR, Coffman RL, et al. (2010) Allergen-specific T cell responses to immunotherapy monitored by CD154 and intracellular cytokine expression. Clin Exp Allergy 40: 1025-1035.
5. Kern F, LiPira G, Gratama JW, Manca F, Roederer M, (2005) Measuring Ag-specific immune responses: understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancer. Trends Immunol 26: 477-484.
6. Janetzki S, Cox JH, Oden N, Ferrari G, (2005) Standardization and validation issues of the ELISPOT assay. Methods Mol Biol 302: 51-86.
7. Moodie Z, Price L, Gouttefangeas C, Mander A, Janetzki S, et al. (2010) Response definition criteria for ELISPOT assays revisited. Cancer Immunol Immunother 59: 1489-1501.
8. Maecker HT, McCoy JP Jr, Consortium FHI, Amos M, Elliott J, et al. (2010) A model for harmonizing flow cytometry in clinical trials. Nat Immunol 11: 975-978.
9. Sharma P, Wagner K, Wolchok JD, Allison JP, (2011) Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nat Rev Cancer 11: 805-812.
10. Freeman JD, Warren RL, Webb JR, Nelson BH, Holt RA, (2009) Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing. Genome Res 19: 1817-1824.
11. Robins HS, Campregher PV, Srivastava SK, Wacher A, Turtle CJ, et al. (2009) Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood 114: 4099-4107.
12. Sherwood AM, Desmarais C, Livingston RJ, Andriesen J, Haussler M, et al. (2011) Deep sequencing of the human TCRgamma and TCRbeta repertoires suggests that TCRbeta rearranges after alphabeta and gammadelta T cell commitment. Sci Transl Med 3: 90ra61.
13. Boyd SD, Marshall EL, Merker JD, Maniar JM, Zhang LN, et al. (2009) Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci Transl Med 1: 12ra23.
14. Warren RL, Freeman JD, Zeng T, Choe G, Munro S, et al. (2011) Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. Genome Res 21: 790-797.
15. Campbell PJ, Pleasance ED, Stephens PJ, Dicks E, Rance R, et al. (2008) Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc Natl Acad Sci U S A 105: 13081-13086.
16. Faham M, Zheng J, Moorhead M, Carlton VE, Stow P, et al. (2012) Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia. Blood 120: 5173-5180.
17. Gawad C, Pepin F, Carlton VE, Klinger M, Logan AC, et al. (2012) Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia. Blood 120: 4407-4417.
18. Chattopadhyay PK, Yu J, Roederer M, (2005) A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat Med 11: 1113-1117.
19. Meier S, Stark R, Frentsch M, Thiel A, (2008) The influence of different stimulation conditions on the assessment of antigen-induced CD154 expression on CD4+ T cells. Cytometry A 73: 1035-1042.
20. Wolfl M, Kuball J, Ho WY, Nguyen H, Manley TJ, et al. (2007) Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood 110: 201-210.
21. Wolfl M, Kuball J, Eyrich M, Schlegel PG, Greenberg PD, (2008) Use of CD137 to study the full repertoire of CD8+ T cells without the need to know epitope specificities. Cytometry A 73: 1043-1049.
22. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, et al. (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281: 65-78.
23. Rubio V, Stuge TB, Singh N, Betts MR, Weber JS, et al. (2003) Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med 9: 1377-1382.
24. Gawad C, Pepin F, Carlton V, Klinger M, Logan AC, et al. (2012) Massive evolution of the immunoglobulin heavy chain locus in children with pediatric B precursor acute lymphoblastic leukemia. Blood Accepted.
25. Lehner PJ, Wang EC, Moss PA, Williams S, Platt K, et al. (1995) Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med 181: 79-91.
26. Moss PA, Moots RJ, Rosenberg WM, Rowland-Jones SJ, Bodmer HC, et al. (1991) Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci U S A 88: 8987-8990.
27. Bousso P, Casrouge A, Altman JD, Haury M, Kanellopoulos J, et al. (1998) Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires. Immunity 9: 169-178.
28. Lim A, Trautmann L, Peyrat MA, Couedel C, Davodeau F, et al. (2000) Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire. J Immunol 165: 2001-2011.
29. Rudd BD, Venturi V, Smithey MJ, Way SS, Davenport MP, et al. (2010) Diversity of the CD8+ T cell repertoire elicited against an immunodominant epitope does not depend on the context of infection. J Immunol 184: 2958-2965.
30. Derre L, Bruyninx M, Baumgaertner P, Ferber M, Schmid D, et al. (2008) Distinct sets of alphabeta TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues. Proc Natl Acad Sci U S A 105: 15010-15015.
31. Babel N, Brestrich G, Gondek LP, Sattler A, Wlodarski MW, et al. (2009) Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes. J Am Soc Nephrol 20: 344-352.
32. Venturi V, Chin HY, Asher TE, Ladell K, Scheinberg P, et al. (2008) TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV. J Immunol 181: 7853-7862.
33. Trautmann L, Rimbert M, Echasserieau K, Saulquin X, Neveu B, et al. (2005) Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses. J Immunol 175: 6123-6132.
34. Retiere C, Prod'homme V, Imbert-Marcille BM, Bonneville M, Vie H, et al. (2000) Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response. J Virol 74: 3948-3952.